​

Funding Round

Seed Round - Visirna Therapeutics

Seed Round - Visirna Therapeutics

Investment Firm

Overview

Visirna Therapeutics to develop and commercialize RNAi therapeutics targeting cardiovascular and metabolic diseases.

Announced Date

Apr 25, 2022

Funding Type

Seed

Highlights

N/A

Location

Asia

Social

N/A

Investor Lead

Vivo Capital

Vivo Capital

Vivo Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorVivo Capital

Round Details and Background

Visirna Therapeutics raised $60000000 on 2022-04-25 in Seed Round

Visirna Therapeutics to develop and commercialize RNAi therapeutics targeting cardiovascular and metabolic diseases.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 25, 2022
Seed Round - Visirna Therapeutics
1-60.0M

Recent Activity

There is no recent news or activity for this profile.